Optimizing the association between disability and biological markers in MS

Neurology

Volumn 57, Issue 7, 2001, Pages 1253-1258

  Kalkers, N F ^a   Bergers, E ^a   Castelijns, J A ^a   Van Walderveen, M A A ^a   Bot, J C J ^a   Ader H J ^a   Polman, C H ^a   Barkhof, F ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN INJURY; BRAIN SIZE; BRAIN VENTRICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISABILITY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NERVE FIBER DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECURRENT DISEASE; TISSUE INJURY;

EID: 0035833970     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.57.7.1253     Document Type: Article

References (39)

1. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis
2. Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: A follow-up study
3. Magnetization transfer ratios and transverse magnetization decay curves in optic neuritis: Correlation with clinical findings and electrophysiology
4. Imaging axonal damage of normal-appearing white matter in multiple sclerosis
5. Clinical outcomes assessment in multiple sclerosis
6. Outcomes assessment in multiple sclerosis clinical trials: A critical analysis
7. The Multiple Sclerosis Functional Composite measure (MSFC): An integrated approach to MS clinical outcome assessment
8. MR outcome parameters in multiple sclerosis: Comparison of surface-based thresholding segmentation and magnetization transfer ratio histographic analysis in relation to disability (a preliminary note)
9. Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis
10. Correlation of volumetric magnetization transfer imaging with clinical data in MS
11. Comparison of multiple sclerosis clinical subgroups using navigated spin echo diffusion-weighted imaging
12. Demyelinating plaques in relapsing-remitting and secondary-progressive multiple sclerosis: Assessment with diffusion MR imaging
13. Neuronal damage in T1-hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy
14. Progressive cerebral atrophy in multiple sclerosis. A serial MRI study
15. A longitudinal study of brain atrophy in relapsing multiple sclerosis
16. Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: Longitudinal quantitative analysis
17. Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology
18. Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability
19. Axonal changes in chronic demyelinated cervical spinal cord plaques
20. Development of a multiple sclerosis functional composite as a clinical trial outcome measure
21. MS functional composite: Relation to disease phenotype and disability strata
22. Concurrent validity of the MS functional composite using MRI as a biological disease marker
23. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms
24. Infratentorial atrophy on magnetic resonance imaging and disability in multiple sclerosis
25. Progressive cerebral atrophy in MS: A serial study using registered, volumetric MRI
26. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS
27. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
28. Defining the clinical course of multiple sclerosis: Results of an international survey
29. Brain atrophy measurements in multiple sclerosis: Intra- and inter-observer reproducibility of 2 methods
30. Comfortable and maximum walking speed of adults aged 20-79 years: Reference values and determinants
31. Upper extremity function in multiple sclerosis: Improving assessment sensitivity with box- and block and nine-hole peg tests
32. Paced auditory serial addition task: A measure of recovery from concussion
33. Paced Auditory Serial Addition Test: Adult norms and moderator variables
34. Detection of ventricular enlargement in patients at the earliest clinical stage of MS
35. The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up
36. Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination
37. Brain atrophy in relapsing-remitting multiple sclerosis: Relationship with 'black holes,' disease duration and clinical disability
38. Brain atrophy in relapsing multiple sclerosis: Relationship to relapses, EDSS, and treatment with interferon beta-1a